Stay updated on Roll-over Study for Continued Pegaspargase in Pediatric ALL Clinical Trial
Sign up to get notified when there's something new on the Roll-over Study for Continued Pegaspargase in Pediatric ALL Clinical Trial page.

Latest updates to the Roll-over Study for Continued Pegaspargase in Pediatric ALL Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.3 was added to the Record History. HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed from the page.SummaryDifference0.2%

- Check43 days agoChange DetectedA new revision entry (v3.3.2) was added to the record history and the previous entry (v3.3.1) removed, reflecting an update to the page's revision log rather than changes to the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedThe study record history shows a new revision entry (v3.3.1) and removal of an existing revision (v3.2.0). These are metadata updates to the revision history and do not affect study data or results.SummaryDifference0.1%

- Check58 days agoChange DetectedThe funding/operating status notice was removed from the page, removing guidance about government funding and NIH operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check72 days agoChange DetectedThe new version updates the study status and recruitment status and notes the Quality Control Review status, reflecting ongoing management of the trial record.SummaryDifference0.1%

- Check100 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the previous version tag (v3.1.0).SummaryDifference12%

Stay in the know with updates to Roll-over Study for Continued Pegaspargase in Pediatric ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roll-over Study for Continued Pegaspargase in Pediatric ALL Clinical Trial page.